课题基金 / 基金详情

REDOX METAL IONS AND NEURONAL PROTEIN DEPOSITION

REDOX METAL IONS AND NEURONAL PROTEIN DEPOSITION
氧化还原金属离子和神经元蛋白沉积
批准号:
2859119
负责人:
Craig S Atwood
金额:
$8.55万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-04-01 至 2000-03-31

项目摘要

项目成果

Craig S Atwood的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A common neuropathological feature of many neurodegenerative diseases, including Alzheimer s disease, Parkinson s disease, Huntington s disease, prion diseases and amyotrophic lateral sclerosis is the presence of focal markers of oxidative stress associated with proteinaceous deposits within the brain. In common with these diseases are a number of cuproproteins such as amyloid protein precursor (APP), prion protein, Huntingtin protein, monoamine oxidase and superoxide dismutase, which are implicated in the pathogenesis of these diseases. Recently, we have reported that APP and Abeta, the major component of amyloid, bind the redox metal ion copper with high affinity and that these proteins are capable of reducing Cu(II), with the subsequent generation of reactive oxygen species. Thus, the ability of Abeta to bind and reduce Cu(II) (and Fe(III) in the case of Abeta) engenders a situation whereby Abeta may be chemically modified, and may explain many of the others oxidative modifications observed in and around amyloid plaques. Indeed, we have shown that in the presence of redox active metals, Abeta forms sodium dodecyl sulphate-resistant polymers like those extracted from the AD brain. Thus, the recently reported uptake of metal ions by Abeta deposits may result in oxidative modifications that lead to the formation of Abeta polymers and the progressive deposition of Abeta into hard core amyloid plaques. It is possible that similar reactions also drive the deposition of other cuproproteins that deposit in neurodegenerative diseases. This study is designed to further characterize metal ion binding to proteins known to deposit within the brain, such as alpha- synuclein in Parkinson s disease, prion protein in prion diseases and Abeta in Alzheimer s disease. In addition, using standard analytical methods, we will test whether metal ions induce the aggregation and/or polymerization of alpha-synuclein and PrP. Finally, we will attempt to locate chemical modifications in these proteins that might explain the mechanism of polymerization. These data will be important in determining the mechanism behind neuronal protein precipitation and may yield insights into how to prevent their deposition in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The LUCINDA Trial
The LUCINDA Trial
The LUCINDA Trial
The LUCINDA Trial
国内基金
海外基金
磷酸化等修饰对TDP-43和Alpha-synuclein等淀粉样蛋白结构及相变的调控机制研究
  • 批准号:
    92053108
  • 项目类别:
    重大研究计划
  • 资助金额:
    70.0万元
  • 批准年份:
    2020
  • 负责人:
    李艳梅
  • 依托单位:
Alpha-Synuclein介导线粒体与突触囊泡相互作用在脑缺血损伤中的作用及机制研究
  • 批准号:
    81971131
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    吴小梅
  • 依托单位:
组蛋白去乙酰化酶2(HDAC2)在alpha-synuclein致小胶质细胞炎性因子异常表达中的作用及机制研究
  • 批准号:
    81971183
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2019
  • 负责人:
    谭玉燕
  • 依托单位:
帕金森病中CDK5磷酸化依赖的C9orf72泛素化降解介导alpha-synuclein清除障碍和神经元死亡的机制研究
  • 批准号:
    81860246
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2018
  • 负责人:
    闫建国
  • 依托单位: